About Terapet
Terapet is a company based in Geneve (Switzerland) founded in 2019 by Raymond Miralbell, Marcus palm, and Christina Vallgren. It operates as a HealthTech. Terapet has raised $3.75 million across 12 funding rounds from investors including Eureka Network, Korea Institute for Advancement of Technology (KIAT) and EFI Lake Geneva Ventures. Terapet offers products and services including Qualyscan and Nuclyscan. Terapet operates in a competitive market with competitors including Advanced Oncotherapy, B dot Medical, P-Cure, HIL Medical and Provision Healthcare, among others.
- Headquarter Geneve, Switzerland
- Founders Raymond Miralbell, Marcus palm, Christina Vallgren
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Terapet Sa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.75 M (USD)
in 12 rounds
-
Latest Funding Round
$1.83 M (USD), Grant
Mar 01, 2024
-
Investors
Eureka Network
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Terapet
Terapet offers a comprehensive portfolio of products and services, including Qualyscan and Nuclyscan. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
An all-in-one solution for proton therapy quality control.
A tool for advancing nuclear imaging technology solutions.
Unlock access to complete
Unlock access to complete
Funding Insights of Terapet
Terapet has successfully raised a total of $3.75M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $1.83 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Grant — $1.8M
-
First Round
First Round
(04 Oct 2019)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Grant - Terapet | Valuation |
investors |
|
| Oct, 2023 | Amount | Grant - Terapet | Valuation |
investors |
|
| Jun, 2023 | Amount | Grant - Terapet | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Terapet
Terapet has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Eureka Network, Korea Institute for Advancement of Technology (KIAT) and EFI Lake Geneva Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated and supported by Fongit in Switzerland.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Terapet
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Terapet
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Terapet Comparisons
Competitors of Terapet
Terapet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Oncotherapy, B dot Medical, P-Cure, HIL Medical and Provision Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of proton beam therapy system for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
Proton beam therapeutic devices for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Image-guided proton therapy for cancer treatment is provided.
|
|
| domain | founded_year | HQ Location |
Proton-beam radiotherapy devices are developed for solid tumor treatment.
|
|
| domain | founded_year | HQ Location |
Proton therapy system for cancer treatment is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Terapet
Frequently Asked Questions about Terapet
When was Terapet founded?
Terapet was founded in 2019.
Where is Terapet located?
Terapet is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Who is the current CEO of Terapet?
Christina Vallgren is the current CEO of Terapet. They have also founded this company.
Is Terapet a funded company?
Terapet is a funded company, having raised a total of $3.75M across 12 funding rounds to date. The company's 1st funding round was a Grant of $2.57M, raised on Oct 04, 2019.
What does Terapet do?
Terapet SA, based in Geneva, is engaged in creating innovative platform technologies for nuclear medicine and proton therapy. The company is dedicated to advancing imaging solutions through products like Qualyscan and Nuclyscan, which are designed to enhance quality control and clinical nuclear imaging in radiotherapy and precision medicine. Their work is supported by collaborations and aims to position their technologies as primary choices in the medical field.
Who are the top competitors of Terapet?
Terapet's top competitors include Advanced Oncotherapy, P-Cure and HIL Medical.
What products or services does Terapet offer?
Terapet offers Qualyscan and Nuclyscan.
Who are Terapet's investors?
Terapet has 12 investors. Key investors include Eureka Network, Korea Institute for Advancement of Technology (KIAT), EFI Lake Geneva Ventures, Nina Capital, and Fongit.